Friend or foe? The current epidemiologic evidence on selenium and human cancer risk

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews

Volumn 31, Issue 4, 2013, Pages 305-341

  Vinceti, Marco ^a   Crespi, Catherine M ^b   Malagoli, Carlotta ^a   Del Giovane, Cinzia ^a   Krogh, Vittorio ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cancer; Epidemiologic studies; Prevention; Risk assessment; Selenium

Indexed keywords

BIOLOGICAL EFFECTS; CANCER; EPIDEMIOLOGIC-STUDY; HEALTHY INDIVIDUALS; LABORATORY STUDIES; PREVENTION; PREVENTIVE AGENTS; RANDOMIZED CONTROLLED TRIAL;

DISEASES; ORGANIC CHEMICALS; RISK ASSESSMENT;

SELENIUM;

ALPHA TOCOPHEROL; GLUTATHIONE PEROXIDASE; HUMAN SERUM ALBUMIN; PLACEBO; PROSTATE SPECIFIC ANTIGEN; SELENATE; SELENITE; SELENIUM; SELENOMETHIONINE; SELENOPROTEIN P; THIOREDOXIN REDUCTASE;

ALOPECIA; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BASAL CELL CARCINOMA; BLADDER CANCER; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER FATIGUE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER THERAPY; CASE CONTROL STUDY; CHEMOPROPHYLAXIS; COHORT ANALYSIS; COLORECTAL CANCER; DERMATITIS; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; FOLLOW UP; GLAUCOMA; GLEASON SCORE; HALITOSIS; HUMAN; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MEDICAL LITERATURE; NAIL; NAUSEA; OBSERVATIONAL STUDY; OCCUPATIONAL EXPOSURE; OVARY CANCER; PHASE 3 CLINICAL TRIAL (TOPIC); PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SIDE EFFECT; SKIN CANCER; SKIN DISEASE; SMOKING HABIT; SQUAMOUS CELL CARCINOMA; VITAMIN SUPPLEMENTATION;

ANIMALS; HUMANS; MICE; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RATS; RISK FACTORS; SELENIUM;

EID: 84888372905     PISSN: 10590501     EISSN: 15324095     Source Type: Journal    
DOI: 10.1080/10590501.2013.844757     Document Type: Article

References (187)

1. Brozmanova J, Manikova D, Vlckova V, Chovanec M. Selenium: a double-edged sword for defense and offence in cancer. Arch Toxicol. 2010;84:919-938.
2. Dennert G, Zwahlen M, Brinkman M, Vinceti M, Zeegers MP, Horneber M. Selenium for preventing cancer. Cochrane Database Syst Rev. 2011;5:CD005195.
3. Bodnar M, Konieczka P, Namiesnik J. The properties, functions, and use of selenium compounds in living organisms. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2012;30:225-252.
4. Steinbrenner H, Speckmann B, Sies H. Towards understanding success and failures in the use of selenium for cancer prevention. Antioxid Redox Signal. 2013;19:181-191.
5. Vinceti M, Maraldi T, Bergomi M, Malagoli C. Risk of chronic low-dose selenium overexposure in humans: insights from epidemiology and biochemistry. Rev Environ Health. 2009;24:231-248.
6. Frost DV. The two faces of selenium-can selenophobia be cured? CRC Crit Rev Toxicol. 1972;1:467-514.
7. Casey CE. Selenophilia. Proc Nutr Soc. 1988;47:55-62.
8. Vinceti M, Solovyev N, Mandrioli J, Crespi CM, Bonvicini F, Arcolin E, Georgoulopoulou E, Michalke B. Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. Neurotoxicology. 2013;38:25-32.
9. Rees K, Hartley L, Day C, Flowers N, Clarke A, Stranges S. Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1:CD009671.
10. Rocourt CR, Wu M, Chen BP, Cheng WH. The catalytic subunit of DNA dependent protein kinase is downstream of ATM and feeds forward oxidative stress in the selenium-induced senescence response. J Nutr Biochem. 2012;24:781-787.
11. Sunde RA. Selenium. In: Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, eds. Modern Nutrition in Health and Disease. 11th Ed. Philadelphia: Lippincott Williams & Wilkins; 2012:225-237.
12. Nelson AA, Fitzhugh OG, Calvery HO. Liver tumors following cirrhosis caused by selenium in rats. Cancer Res. 1943;3:230-236.
13. Birt DF, Julius AD, Runice CE, White LT, Lawson T, Pour PM. Enhancement of BOP-induced pancreatic carcinogenesis in selenium-fed Syrian golden hamsters under specific dietary conditions. Nutr Cancer. 1988;11:21-33.
14. National Toxicology Program. Selenium sulfide. Rep Carcinog. 2011;12:376-377.
15. Clayton CC, Baumann CA. Diet and azo dye tumors: effect of diet during a period when the dye is not fed. Cancer Res. 1949;9:575-582.
16. Jackson MI, Combs GF Jr. Selenium and anticarcinogenesis: underlying mechanisms. Curr Opin Clin Nutr Metab Care. 2008;11:718-726.
17. Csallany AS, Su LC, Menken BZ. Effect of selenite, vitamin E and N, N'-diphenylp-phenylenediamine on liver organic solvent-soluble lipofuscin pigments in mice. J Nutr. 1984;114:1582-1587.
18. Lu J, Jiang C, Kaeck M, Ganther H, Vadhanavikit S, Ip C, Thompson H. Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem Pharmacol. 1995;50:213-219.
19. Hatfield DL, Yoo MH, Carlson BA, Gladyshev VN. Selenoproteins that function in cancer prevention and promotion. Biochim Biophys Acta. 2009;1790:1541-1545.
20. Kasaikina MV, Lobanov AV, Malinouski MY, Lee BC, Seravalli J, Fomenko DE, et al. Reduced utilization of selenium by naked mole rats due to a specific defect in GPx1 expression. J Biol Chem. 2011;286:17005-17014.
21. Shamberger RJ, Frost DV. Possible protective effect of selenium against human cancer. Can Med Assoc J. 1969;100:682.
22. Shamberger RJ, Tytko SA, Willis CE. Antioxidants and cancer. Part VI. Selenium and age-adjusted human cancer mortality. Arch Environ Health. 1976;31:231-235
23. Schrauzer GN, White DA, Schneider CJ. Cancer mortality correlation studies-III: statistical associations with dietary selenium intakes. Bioinorg Chem. 1977;7:23-31.
24. Jansson B, Jacobs MM, Griffin AC. Gastrointestinal cancer: epidemiology and experimental studies. Adv Exp Med Biol. 1978;91:305-321.
25. Cech I, Holguin A, Sokolow H, Smith V. Selenium availability in Texas: possible clinical significance. South Med J. 1984;77:1415-1420.
26. Clark LC, Cantor KP, Allaway WH. Selenium in forage crops and cancer mortality in U.S. counties. Arch Environ Health. 1991;46:37-42.
27. Vinceti M, Rovesti S, Bergomi M, Vivoli G. The epidemiology of selenium and human cancer. Tumori. 2000;86:105-118.
28. Guo W, Chow W, Zheng W, Li J, Blot WJ. Diet, serum markers and breast cancer mortality in China. Jpn J Cancer Res. 1994;85:572-577.
29. Semnani S, Roshandel G, Zendehbad A, Keshtkar A, Rahimzadeh H, Abdolahi N, Besharat S, Moradi A, Mirkarimi H, Hasheminasab S. Soils selenium level and esophageal cancer: an ecological study in a high risk area for esophageal cancer. J Trace Elem Med Biol. 2010;24:174-177.
30. Zhang L, Lv J, Liao C. Dietary exposure estimates of 14 trace elements in Xuanwei and Fuyuan, two high lung cancer incidence areas in China. Biol Trace Elem Res. 2012;146:287-292.
31. Krogh V, Pala V, Vinceti M, Berrino F, Ganzi A, Micheli A, et al. Toenail selenium as biomarker: reproducibility over a one-year period and factors influencing reproducibility. J Trace Elem Med Biol. 2003;17 (Suppl 1):31-36.
32. Solovyev N, Berthele A, Michalke B. Selenium speciation in paired serum and cerebrospinal fluid samples. Anal Bioanal Chem. 2013;405:1875-1884.
33. Swanson CA, Longnecker MP, Veillon C, Howe M, Levander OA, Taylor PR, McAdam PA, Brown CC, Stampfer MJ, Willett WC. Selenium intake, age, gender, and smoking in relation to indices of selenium status of adults residing in a seleniferous area. Am J Clin Nutr. 1990;52:858-862.
34. van den Brandt PA, Goldbohm RA, van't Veer P, Bode P, Hermus RJ, Sturmans F. Predictors of toenail selenium levels in men and women. Cancer Epidemiol Biomarkers Prev. 1993;2:107-112.
35. Ovaskainen ML, Virtamo J, Alfthan G, Haukka J, Pietinen P, Taylor PR, Huttunen JK. Toenail selenium as an indicator of selenium intake among middle-aged men in an area with low soil selenium. Am J Clin Nutr. 1993;57:662-665.
36. Longnecker MP, Stram DO, Taylor PR, Levander OA, Howe M, Veillon C, et al. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology. 1996;7:384-390.
37. Pestitschek M, Sonneck-Koenne C, Zakavi SR, Li S, Knoll P, Mirzaei S. Selenium intake and selenium blood levels: a novel food frequency questionnaire. Wien Klin Wochenschr. 2013;125:160-164.
38. Hunter DJ, Morris JS, Chute CG, Kushner E, Colditz GA, Stampfer MJ, Speizer FE, Willett WC. Predictors of selenium concentration in human toenails. Am J Epidemiol. 1990;132:114-122.
39. Karita K, Sasaki S, Ishihara J, Tsugane S. Validity of a self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC Study to assess selenium intake: comparison with dietary records and blood levels. J Epidemiol. 2003;13:S92-97.
40. Satia JA, King IB, Morris JS, Stratton K, White E. Toenail and plasma levels as biomarkers of selenium exposure. Ann Epidemiol. 2006;16:53-58.
41. Salbe AD, Levander OA. Effect of various dietary factors on the deposition of selenium in the hair and nails of rats. J Nutr. 1990;120:200-206.
42. Salbe AD, Levander OA. Comparative toxicity and tissue retention of selenium in methionine-deficient rats fed sodium selenate or L-selenomethionine. J Nutr. 1990;120:207-212.
43. Panter KE, Hartley WJ, James LF, Mayland HF, Stegelmeier BL, Kechele PO. Comparative toxicity of selenium from seleno-DL-methionine, sodium selenate, and Astragalus bisulcatus in pigs. Fund Appl Toxicol. 1996;32:217-223.
44. Ashton K, Hooper L, Harvey LJ, Hurst R, Casgrain A, Fairweather-Tait SJ. Methods of assessment of selenium status in humans: a systematic review. Am J Clin Nutr. 2009;89:2025S-2039S.
45. Maraldi T, Riccio M, Zambonin L, Vinceti M, De Pol A, Hakim G. Low levels of selenium compounds are selectively toxic for a human neuron cell line through ROS/RNS increase and apoptotic process activation. Neurotoxicology. 2011;32:180-187.
46. Thomas JK, Janz DM. Dietary selenomethionine exposure in adult zebrafish alters swimming performance, energetics and the physiological stress response. Aquat Toxicol. 2011;102:79-86.
47. Lu Y, Zhang A, Li C, Zhang P, Su X, Li Y, Mu C, Li T. The link between selenium binding protein from Sinonovacula constricta and environmental pollutions exposure. Fish Shellfish Immunol. 2013;35:271-277.
48. Pacitti D, Wang T, Page MM, Martin SA, Sweetman J, Feldmann J, Secombes CJ. Characterization of cytosolic glutathione peroxidase and phospholipid-hydroperoxide glutathione peroxidase genes in rainbow trout (Oncorhynchus mykiss) and their modulation by in vitro selenium exposure. Aquat Toxicol. 2013;130-131:97-111.
49. Lee EH, Myung SK, Jeon YJ, Kim Y, Chang YJ, Ju W, Seo HG, Huh BY. Effects of selenium supplements on cancer prevention: meta-analysis of randomized controlled trials. Nutr Cancer. 2011;63:1185-1195.
50. Hurst R, Hooper L, Norat T, Lau R, Aune D, Greenwood DC, et al. Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr. 2012;96:111-122.
51. Takata Y, Kristal AR, King IB, Song X, Diamond AM, Foster CB, et al. Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the Women's Health Initiative Observational Study and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2011;20:1822-1830.
52. Hansen RD, Albieri V, Tjonneland A, Overvad K, Andersen KK, Raaschou-Nielsen O. Effects of smoking and antioxidant micronutrients on risk of colorectal cancer. Clin Gastroenterol Hepatol. 2013;11:406-415 e3.
53. Menkes MS, Comstock GW, Vuilleumier JP, Helsing KJ, Rider AA, Brookmeyer R. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med. 1986;315:1250-1254.
54. van Noord PA, Maas MJ, van der Tweel I, Collette C. Selenium and the risk of postmenopausal breast cancer in the DOM cohort. Breast Cancer Res Treat. 1993;25:11-19.
55. Garland M, Morris JS, Stampfer MJ, Colditz GA, Spate VL, Baskett CK, Rosner B, Speizer FE, Willett WC, Hunter DJ. Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst. 1995;87:497-505.
56. Hartman TJ, Albanes D, Pietinen P, Hartman AM, Rautalahti M, Tangrea JA, Taylor PR. The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev. 1998;7:335-340.
57. Ratnasinghe D, Tangrea JA, Forman MR, Hartman T, Gunter EW, Qiao YL, et al. Serum tocopherols, selenium and lung cancer risk among tin miners in China. Cancer Causes Control. 2000;11:129-135.
58. Suadicani P, Hein HO, Gyntelberg F. Serum selenium level and risk of lung cancer mortality: a 16-year follow-up of the Copenhagen Male Study. Eur Respir J. 2012;39:1443-1448.
59. Salonen JT, Alfthan G, Huttunen JK, Puska P. Association between serum selenium and the risk of cancer. Am J Epidemiol. 1984;120:342-349.
60. Knekt P, Aromaa A, Maatela J, Alfthan G, Aaran RK, Hakama M, Hakulinen T, Peto R, Teppo L. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst. 1990;82:864-868.
61. Combs GF Jr. Selenium in global food systems. Br J Nutr. 2001;85:517-547.
62. Valdiglesias V, Pasaro E, Mendez J, Laffon B. In vitro evaluation of selenium genotoxic, cytotoxic, and protective effects: a review. Arch Toxicol. 2010;84:337-351.
63. Nogueira CW, Rocha JB. Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds. Arch Toxicol. 2011;85:1313-1359.
64. Benko I, Nagy G, Tanczos B, Ungvari E, Sztrik A, Eszenyi P, Prokisch J, Banfalvi G. Subacute toxicity of nano-selenium compared to other selenium species in mice. Environ Toxicol Chem. 2012;31:2812-2820.
65. Weekley CM, Aitken JB, Finney L, Vogt S, Witting PK, Harris HH. Selenium metabolism in cancer cells: the combined application of XAS and XFM techniques to the problem of selenium speciation in biological systems. Nutrients. 2013;5:1734-1756.
66. Hazane-Puch F, Champelovier P, Arnaud J, Garrel C, Ballester B, Faure P, Laporte F. Long-term selenium supplementation in HaCaT cells: importance of chemical form for antagonist (protective versus toxic) activities. Biol Trace Elem Res. 2013;154:288-298.
67. Borella P, Bargellini A, Medici CI. Chemical form of selenium greatly affects metal uptake and responses by cultured human lymphocytes. Biol Trace Elem Res. 1996;51:43-54.
68. Kim CY, Kim GN, Wiacek JL, Chen CY, Kim KH. Selenate inhibits adipogenesis through induction of transforming growth factor-beta1 (TGF-beta1) signaling. Biochem Biophys Res Commun. 2012;426:551-557.
69. Kipp AP, Frombach J, Deubel S, Brigelius-Flohe R. Selenoprotein w as biomarker for the efficacy of selenium compounds to act as source for selenoprotein biosynthesis. Methods Enzymol. 2013;527:87-112.
70. Davis TZ, Stegelmeier BL, Welch KD, Pfister JA, Panter KE, Hall JO. Comparative oral dose toxicokinetics of selenium compounds commonly found in selenium accumulator plants. J Anim Sci. 2013;91:4501-4509.
71. Zwolak I, Zaporowska H. Selenium interactions and toxicity: a review: Selenium interactions and toxicity. Cell Biol Toxicol. 2012;28:31-46.
72. George CM, Gamble M, Slavkovich V, Levy D, Ahmed A, Ahsan H, Graziano J. A cross-sectional study of the impact of blood selenium on blood and urinary arsenic concentrations in Bangladesh. Environ Health. 2013;12:52.
73. Shiobara Y, Yoshida T, Suzuki KT. Effects of dietary selenium species on Se concentrations in hair, blood, and urine. Toxicol Appl Pharmacol. 1998;152:309-314.
74. Behne D, Gessner H, Kyriakopoulos A. Information on the selenium status of several body compartments of rats from the selenium concentrations in blood fractions, hair and nails. J Trace Elem Med Biol. 1996;10:174-179.
75. Scharpf M, Schweizer U, Arzberger T, Roggendorf W, Schomburg L, Kohrle J. Neuronal and ependymal expression of selenoprotein P in the human brain. J Neural Transm. 2007;114:877-884.
76. Antunes Soares F, Farina M, Boettcher AC, Braga AL, Batista TRJ. Organic and inorganic forms of selenium inhibited differently fish (Rhamdia quelen) and rat (Rattus norvergicus albinus) delta-aminolevulinate dehydratase. Environ Res. 2005;98: 46-54.
77. Xiao R, Qiao JT, Zhao HF, Liang J, Yu HL, Liu J, Guo AM, Wang W. Sodium selenite induces apoptosis in cultured cortical neurons with special concomitant changes in expression of the apoptosis-related genes. Neurotoxicology. 2006;27:478-484.
78. Ayaz M, Dalkilic N, Tuncer S, Bariskaner H. Selenium-induced changes on rat sciatic nerve fibers: compound action potentials. Methods Find Exp Clin Pharmacol. 2008;30:271-275.
79. Nischwitz V, Berthele A, Michalke B. Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: an approach to investigate the permeability of the human blood-cerebrospinal fluidbarrier. Anal Chim Acta. 2008;627:258-269.
80. Michalke B, Halbach S, Nischwitz V. JEM spotlight: metal speciation related to neurotoxicity in humans. J Environ Monit. 2009;11:939-954.
81. Steinbrecher A, Meplan C, Hesketh J, Schomburg L, Endermann T, Jansen E, Akesson B, Rohrmann S, Linseisen J. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol Biomarkers Prev. 2010;19:2958-2968.
82. Slattery ML, Lundgreen A, Welbourn B, Corcoran C, Wolff RK. Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer. PLoS One. 2012;7:e37312.
83. Meplan C, Hesketh J. The influence of selenium and selenoprotein gene variants on colorectal cancer risk. Mutagenesis. 2012;27:177-186.
84. Jablonska E, Gromadzinska J, Sobala W, Reszka E, Wasowicz W. Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism. Eur J Nutr. 2008;47:47-54.
85. Chan JM, Oh WK, Xie W, Regan MM, Stampfer MJ, King IB, Abe M, Kantoff PW. Plasma selenium, manganese superoxide dismutase, and intermediate-or highrisk prostate cancer. J Clin Oncol. 2009;27:3577-3583.
86. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey SM, Li B. The Linxian trials: mortality rates by vitamin-mineral intervention group. Am J Clin Nutr. 1995;62:1424S-1426S.
87. Hercberg S, Ezzedine K, Guinot C, Preziosi P, Galan P, Bertrais S, et al. Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr. 2007;137:2098-2105.
88. Ezzedine K, Latreille J, Kesse-Guyot E, Galan P, Hercberg S, Guinot C, Malvy D. Incidence of skin cancers during 5-year follow-up after stopping antioxidant vitamins and mineral supplementation. Eur J Cancer. 2010;46:3316-3322.
89. Li H, Li HQ, Wang Y, Xu HX, Fan WT, Wang ML, Sun PH, Xie XY. An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum. Chin Med J (Engl). 2004;117:1155-1160.
90. Yu SY, Zhu YJ, Li WG, Huang QS, Huang CZ, Zhang QN, Hou C. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res. 1991;29:289-294.
91. Yu SY, Zhu YJ, Li WG. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res. 1997;56:117-124.
92. Li W, Zhu Y, Yan X, Zhang Q, Li X, Ni Z, Shen Z, Yao H, Zhu J. [The prevention of primary liver cancer by selenium in high risk populations]. Zhonghua Yu Fang Yi Xue Za Zhi. 2000;34:336-338.
93. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GFJ, Slate EH, Fischbach LA, Marshall JR, Clark LC. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev. 2002;11:630-639.
94. Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF Jr, et al. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst. 2003;95:1477-1481.
95. Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, Marshall JR, Clark LC. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int. 2003;91:608-612.
96. Marshall JR, Tangen CM, Sakr WA, Wood DP Jr, Berry DL, Klein EA, et al. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila). 2011;4:1761-1769.
97. Algotar AM, Stratton MS, Ahmann FR, Ranger-Moore J, Nagle RB, Thompson PA, et al. Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate. 2013;73:328-335.
98. Dreno B, Euvrard S, Frances C, Moyse D, Nandeuil A. Effect of selenium intake on the prevention of cutaneous epithelial lesions in organ transplant recipients. Eur J Dermatol. 2007;17:140-145.
99. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301: 39-51.
100. Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306:1549-1556.
101. Lubinski J, Jaworska K, Durda K, Jakubowska A, Huzarski T, Byrski T, et al. Selenium and the risk of cancer in BRCA1 carriers. Hered Cancer Clin Pract. 2011;9 (Suppl 2):A5.
102. Clark LC, Combs GFJ, Turnbull BW, Slate EH, Chalker DK, Chow J, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996;276:1957-1963.
103. Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR. Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev. 2002;11:1285-1291.
104. Reid ME, Stratton MS, Lillico AJ, Fakih M, Natarajan R, Clark LC, Marshall JR. A report of high-dose selenium supplementation: response and toxicities. J Trace Elem Med Biol. 2004;18:69-74.
105. Dalkin BW, Lillico AJ, Reid ME, Jacobs ET, Combs GF, Slate E, Turnbull BW, Marshall JR, eds. Selenium and chemoprevention against prostate cancer: an update of the Clark results. 92nd Meeting of the American Association for Cancer Research. 2001; New Orleans, LA: American Association for Cancer Research.
106. Willett WC, Polk BF, Morris JS, Stampfer MJ, Pressel S, Rosner B, Taylor JO, Schneider K, Hames CG. Prediagnostic serum selenium and risk of cancer. Lancet. 1983;2:130-134.
107. Salonen JT, Salonen R, Lappetelainen R, Maenpaa PH, Alfthan G, Puska P. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J. 1985;290:417-420.
108. Peleg I, Morris S, Hames CG. Is serum selenium a risk factor for cancer? Med Oncol Tumor Pharmacother. 1985;2:157-163.
109. Kok FJ, de Bruijn AM, Hofman A, Vermeeren R, Valkenburg HA. Is serum selenium a risk factor for cancer in men only? Am J Epidemiol. 1987;125:12-16.
110. Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM Jr, Kristal AR, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005;97:94-102.
111. Goodman PJ, Hartline JA, Tangen CM, Crowley JJ, Minasian LM, Klein EA, et al. Moving a randomized clinical trial into an observational cohort. Clin Trials. 2013;10:131-142.
112. Kristal AR, Lippman SM. Nutritional prevention of cancer: new directions for an increasingly complex challenge. J Natl Cancer Inst. 2009;101:363-365.
113. Lotan Y, Goodman PJ, Youssef RF, Svatek RS, Shariat SF, Tangen CM, Thompson IM Jr, Klein EA. Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT. J Urol. 2012;187:2005-2010.
114. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, Cappuccio FP, Ceriello A, Reid ME. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147:217-223
115. Moyad MA. Heart healthy = prostate healthy: SELECT, the symbolic end of preventing prostate cancer via heart unhealthy and over anti-oxidation mechanisms? Asian J Androl. 2012;14:243-244.
116. Haldimann M, Venner TY, Zimmerli B. Determination of selenium in the serum of healthy Swiss adults and correlation to dietary intake. J Trace Elem Med Biol. 1996;10:31-45.
117. World Health Organization. Trace elements in human nutrition and health. 1996; Geneva, Switzerland: WHO press.
118. Leblanc JC, Guerin T, Noel L, Calamassi-Tran G, Volatier JL, Verger P. Dietary exposure estimates of 18 elements from the 1st French Total Diet Study. Food Addit Contam. 2005;22:624-641.
119. Vinceti M, Nacci G, Rocchi E, Cassinadri T, Vivoli R, Marchesi C, Bergomi M. Mortality in a population with long-term exposure to inorganic selenium via drinking water. J Clin Epidemiol. 2000;53:1062-1068.
120. Marshall JR, Reid ME, Lillico A. Nutritional prevention of cancer: review of glaucoma data. Tucson: University of Arizona; 2002.
121. Vinceti M, Rothman KJ, Bergomi M, Borciani N, Serra L, Vivoli G. Excess melanoma incidence in a cohort exposed to high levels of environmental selenium. Cancer Epidemiol Biomarkers Prev. 1998;7:853-856.
122. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43-46.
123. Reid ME, Duffield-Lillico AJ, Slate E, Natarajan N, Turnbull B, Jacobs E, Combs GF Jr, Alberts DS, Clark LC, Marshall JR. The nutritional prevention of cancer: 400 mcg per day selenium treatment. Nutr Cancer. 2008;60:155-163.
124. Fleshner NE, Kapusta L, Donnelly B, Tanguay S, Chin J, Hersey K, et al. Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium. J Clin Oncol. 2011;29:2386-2390.
125. Stratton MS, Reid ME, Schwartzberg G, Minter FE, Monroe BK, Alberts DS, Marshall JR, Ahmann FR. Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study. Anticancer Drugs. 2003;14:589-594.
126. Penney KL, Schumacher FR, Li H, Kraft P, Morris JS, Kurth T, Mucci LA, Hunter DJ, Kantoff PW, Stampfer MJ, Ma J. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res (Phila). 2010;3:604-610.
127. Lawson KA, Wright ME, Subar A, Mouw T, Hollenbeck A, Schatzkin A, Leitzmann MF. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst. 2007;99:754-764.
128. Zhang Y, Coogan P, Palmer JR, Strom BL, Rosenberg L. Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study. Cancer Causes Control. 2009;20:691-698.
129. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Edition T, ed. Philadelphia: Lippincott Williams & Wilkins; 2008.
130. Vinceti M, Rovesti S, Gabrielli C, Marchesi C, Bergomi M, Martini M, Vivoli G. Cancer mortality in a residential cohort exposed to environmental selenium through drinking water. J Clin Epidemiol. 1995;48:1091-1097.
131. Ammar EM, Couri D. Acute toxicity of sodium selenite and selenomethionine in mice after ICV or IV administration. Neurotoxicology. 1981;2:383-386.
132. Vinceti M, Crespi CM, Bonvicini F, Malagoli C, Ferrante M, Marmiroli S, Stranges S. The need for a reassessment of the safe upper limit of selenium in drinking water. Sci Total Environ. 2013;443:633-642.
133. Institute of Medicine. Dietary references intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press; 2000.
134. Nordic Nutrition Recommendations 2004.4th Edition ed. Copenhagen: Nordic Council of Ministers; 2004.
135. Levander OA. Selenium requirements as discussed in the 1996 joint FAO/IAEA/WHO expert consultation on trace elements in human nutrition. Biomed Environ Sci. 1997;10:214-219.
136. Reszka E, Jablonska E, Gromadzinska J, Wasowicz W. Relevance of selenoprotein transcripts for selenium status in humans. Genes Nutr. 2012;7:127-137.
137. Macallan DC, Sedgwick P. Selenium supplementation and selenoenzyme activity. Clin Sci. 2000;99:579-281.
138. Brätter P, Negretti de Brätter VE. Influence of high dietary intake on the thyroid hormone level in human serum. J Trace Elem Med Biol. 1996;10:163-166.
139. Stranges S, Sieri S, Vinceti M, Grioni S, Guallar E, Laclaustra M, Muti P, Berrino F, Krogh V. A prospective study of dietary selenium intake and risk of type 2 diabetes. BMC Public Health. 2010;10:564.
140. Hafeman DG, Sunde RA, Hoekstra WG. Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J Nutr. 1974;104:580-587.
141. Kramer GF, Ames BN. Mechanisms of mutagenicity and toxicity of sodium selenite (Na2SeO3) in Salmonella typhimurium. Mutat Res. 1988;201:169-180.
142. Sinha R, Sinha I, Facompre N, Russell S, Somiari RI, Richie JP Jr, El-Bayoumy K. Selenium-responsive proteins in the sera of selenium-enriched yeast-supplemented healthy African American and Caucasian men. Cancer Epidemiol Biomarkers Prev. 2010;19:2332-2340.
143. Loison F, Debure L, Nizard P, le Goff P, Michel D, le Drean Y. Up-regulation of the clusterin gene after proteotoxic stress: implication of HSF1-HSF2 heterocomplexes. Biochem J. 2006;395:223-231.
144. Trougakos IP. The molecular chaperone apolipoprotein J/clusterin as a sensor of oxidative stress: implications in therapeutic approaches-a mini-review. Gerontology. 2013 (in press).
145. Chen Q, Wang Z, Xiong Y, Zou X, Liu Z. Comparative study of p38 MAPK signal transduction pathway of peripheral blood mononuclear cells from patients with coalcombustion-type fluorosis with and without high hair selenium levels. Int J Hyg Environ Health. 2010;213:381-386.
146. Karunasinghe N, Han DY, Zhu S, Yu J, Lange K, Duan H, et al. Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: relationship to markers of oxidative stress in men from Auckland, New Zealand. Genes Nutr. 2012;7:179-190.
147. Koyama H, Mutakin, Abdulah R, Yamazaki C, Kameo S. Selenium supplementation trials for cancer prevention and the subsequent risk of type 2 diabetes mellitus. Nihon Eiseigaku Zasshi. 2013;68:1-10.
148. Lillico A, Jacobs E, Reid ME. Selenium supplementations and risk of glaucoma in the NPC trial. Tucson: University of Arizona; 2002.
149. Bruhn RL, Stamer WD, Herrygers LA, Levine JM, Noecker RJ. Relationship between glaucoma and selenium levels in plasma and aqueous humour. Br J Ophthalmol. 2009;93:1155-1158.
150. Vinceti M, Bonvicini F, Rothman KJ, Vescovi L, Wang F. The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a populationbased case-control study. Environ Health. 2010;9:77.
151. Conley SM, Bruhn RL, Morgan PV, Stamer WD. Selenium's effects on MMP-2 and TIMP-1 secretion by human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2004;45:473-479.
152. Casteignau A, Fontan A, Morillo A, Oliveros JA, Segales J. Clinical, pathological and toxicological findings of a iatrogenic selenium toxicosis case in feeder pigs. J Vet Med A Physiol Pathol Clin Med. 2006;53:323-326.
153. Tsunoda M, Johnson VJ, Sharma RP. Increase in dopamine metabolites in murine striatum after oral exposure to inorganic but not organic form of selenium. Arch Environ Contam Toxicol. 2000;39:32-37.
154. Vinceti M, Guidetti D, Pinotti M, Rovesti S, Merlin M, Vescovi L, Bergomi M, Vivoli G. Amyotrophic lateral sclerosis after long-term exposure to drinking water with high selenium content. Epidemiology. 1996;7:529-532.
155. Vinceti M, Wei ET, Malagoli C, Bergomi M, Vivoli G. Adverse health effects of selenium in humans. Rev Environ Health. 2001;16:233-251.
156. Ravn-Haren G, Krath BN, Overvad K, Cold S, Moesgaard S, Larsen EH, Dragsted LO. Effect of long-term selenium yeast intervention on activity and gene expression of antioxidant and xenobiotic metabolising enzymes in healthy elderly volunteers from the Danish Prevention of Cancer by Intervention by Selenium (PRECISE) pilot study. Br J Nutr. 2008;99:1190-1198.
157. Saint-Amour D, Roy MS, Bastien C, Ayotte P, Dewailly E, Despres C, Gingras S, Muckle G. Alterations of visual evoked potentials in preschool Inuit children exposed to methylmercury and polychlorinated biphenyls from a marine diet. Neurotoxicology. 2006;27:567-578.
158. Berthold HK, Michalke B, Krone W, Guallar E, Gouni-Berthold I. Influence of serum selenium concentrations on hypertension: the Lipid Analytic Cologne crosssectional study. J Hypertens. 2012;30:1328-1335.
159. Platz EA, Lippman SM. Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial. J Clin Oncol. 2009;27:3569-3572.
160. Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, et al. Selenium and the course of mild Graves' orbitopathy. N Engl J Med. 2011;364:1920-1931.
161. Goossens ME, Buntinx F, Joniau S, Ackaert K, Ameye F, Billiet I, et al. Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium. BMC Urol. 2012;12:8.
162. Bhattacharya A, Turowski SG, San Martin ID, Rajput A, Rustum YM, Hoffman RM, Seshadri M. Magnetic resonance and fluorescence-protein imaging of the antiangiogenic and anti-tumor efficacy of selenium in an orthotopic model of human colon cancer. Anticancer Res. 2011;31:387-393.
163. Desai D, Sinha I, Null K, Wolter W, Suckow MA, King T, Amin S, Sinha R. Synthesis and antitumor properties of selenocoxib-1 against rat prostate adenocarcinoma cells. Int J Cancer. 2010;127:230-238.
164. Nguyen N, Sharma A, Sharma AK, Desai D, Huh SJ, Amin S, Meyers C, Robertson GP. Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4. Cancer Prev Res (Phila). 2011;4:248-258.
165. Cheng Y, Sk UH, Zhang Y, Ren X, Zhang L, Huber-Keener KJ, et al. Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death. PLoS One. 2012;7:e35104.
166. Qi Y, Fu X, Xiong Z, Zhang H, Hill SM, Rowan BG, Dong Y. Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer. PLoS One. 2012;7:e31539.
167. Zheng S, Li X, Zhang Y, Xie Q, Wong YS, Zheng W, Chen T. PEG-nanolized ultrasmall selenium nanoparticles overcome drug resistance in hepatocellular carcinoma HepG2 cells through induction of mitochondria dysfunction. Int J Nanomedicine. 2012;7:3939-3949.
168. Gowda R, Madhunapantula SV, Desai D, Amin S, Robertson GP. Simultaneous targeting of COX-2 and AKT using selenocoxib-1-GSH to inhibit melanoma. Mol Cancer Ther. 2013;12:3-15.
169. Li F, Jiang Q, Shi KJ, Luo H, Yang Y, Xu CM. RhoA modulates functional and physical interaction between ROCK1 and Erk1/2 in selenite-induced apoptosis of leukaemia cells. Cell Death Dis. 2013;4:e708.
170. Dos Santos ED, Hamel E, Bai R, Burnett JC, Tozatti CS, Bogo D, et al. Synthesis and evaluation of diaryl sulfides and diaryl selenide compounds for antitubulin and cytotoxic activity. Bioorg Med Chem Lett. 2013;23:4669-4673.
171. Huang Y, He L, Liu W, Fan C, Zheng W, Wong YS, Chen T. Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles. Biomaterials. 2013;34:7106-7116.
172. Kim YW, Bae SM, Liu HB, Kim IW, Chun HJ, Ahn WS. Selenium enhances the efficacy of Radachlorin mediated-photodynamic therapy in TC-1 tumor development. Oncol Rep. 2012;28:576-584.
173. Chintala S, Najrana T, Toth K, Cao S, Durrani FA, Pili R, Rustum YM. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxiainducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition. BMC Cancer. 2012;12:293.
174. Sonaa E, Usha S, Ja In J. An ex vivo study of selenium, genistein on the morphological and nuclear changes in anticancer drug-induced apoptosis in human peripheral blood lymphocytes. Biofactors. 2013;39:279-293.
175. Zeng H, Briske-Anderson M, Wu M, Moyer MP. Methylselenol, a selenium metabolite, plays common and different roles in cancerous colon HCT116 cell and noncancerous NCM460 colon cell proliferation. Nutr Cancer. 2012;64:128-135.
176. Weiller M, Latta M, Kresse M, Lucas R, Wendel A. Toxicity of nutritionally available selenium compounds in primary and transformed hepatocytes. Toxicology. 2004;201:21-30.
177. Asfour IA, El-Tehewi MM, Ahmed MH, Abdel-Sattar MA, Moustafa NN, Hegab HM, Fathey OM. High-dose sodium selenite can induce apoptosis of lymphoma cells in adult patients with non-Hodgkin's lymphoma. Biol Trace Elem Res. 2009;127:200-210.
178. Karp DD, Lee SJ, Keller SM, Wright GS, Aisner S, Belinsky SA, Johnson DH, Johnston MR, Goodman G, Clamon G, Okawara G, Marks R, Frechette E, McCaskill-Stevens W, Lippman SM, Ruckdeschel J, Khuri FR. Randomized, Double-Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Patients With Resected Stage I Non-Small-Cell Lung Cancer: ECOG 5597.J Clin Oncol. 2013 (in press).
179. Niraula S, Pond G, de Wit R, Eisenberger M, Tannock IF, Joshua AM. Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study. Can Urol Assoc J. 2013;7:E74-81.
180. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst. 2008;100:773-783.
181. Buntzel J, Riesenbeck D, Glatzel M, Berndt-Skorka R, Riedel T, Mucke R, et al. Limited effects of selenium substitution in the prevention of radiation-associated toxicities. results of a randomized study in head and neck cancer patients. Anticancer Res. 2010;30:1829-1832.
182. Chen YC, Prabhu KS, Das A, Mastro AM. Dietary selenium supplementation modifies breast tumor growth and metastasis. Int J Cancer. 2013;133:2054-2064.
183. Zhuo H, Smith AH, Steinmaus C. Selenium and lung cancer: a quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiol Biomarkers Prev. 2004;13:771-778.
184. Cortes-Jofre M, Rueda JR, Corsini-Munoz G, Fonseca-Cortes C, Caraballoso M, Bonfill Cosp X. Drugs for preventing lung cancer in healthy people. Cochrane Database Syst Rev. 2012;10:CD002141.
185. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2008:CD007176.
186. Marik PE, Flemmer M. Do dietary supplements have beneficial health effects in industrialized nations: what is the evidence? JPEN J Parenter Enteral Nutr. 2012;36:159-168.
187. Mayne ST, Ferrucci LM, Cartmel B. Lessons learned from randomized clinical trials of micronutrient supplementation for cancer prevention. Annu Rev Nutr. 2012;32:369-390.